Literature DB >> 23695381

Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.

Chien-Hung Lin1, Tsung-Che Chang, Anindya Das, Ming-Yu Fang, Hui-Chen Hung, Kai-Cheng Hsu, Jinn-Moon Yang, Mark von Itzstein, Kwok Kong T Mong, Tsu-An Hsu, Chun-Cheng Lin.   

Abstract

A series of acylguanidine-modified zanamivir analogs were synthesized and their inhibitory activities against the NAs of avian influenza viruses (H1N1 and H3N2) were evaluated. In particular, zanamivir derivative , with a hydrophobic naphthalene substituent, exhibits the best inhibitory activity against group-1 NA with an IC50 of 20 nM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695381     DOI: 10.1039/c3ob40624e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Diastereoselective synthesis of 3,4-dihydro-2H-pyran-4-carboxamides through an unusual regiospecific quasi-hydrolysis of a cyano group.

Authors:  Mikhail Yu Ievlev; Oleg V Ershov; Mikhail Yu Belikov; Angelina G Milovidova; Viktor A Tafeenko; Oleg E Nasakin
Journal:  Beilstein J Org Chem       Date:  2016-09-27       Impact factor: 2.883

2.  Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.

Authors:  Dhwani Dholakia; Sukriti Goyal; Salma Jamal; Aditi Singh; Asmita Das; Abhinav Grover
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

Review 3.  Development of effective anti-influenza drugs: congeners and conjugates - a review.

Authors:  Jiun-Jie Shie; Jim-Min Fang
Journal:  J Biomed Sci       Date:  2019-10-23       Impact factor: 8.410

4.  Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus.

Authors:  Luis Márquez-Domínguez; Julio Reyes-Leyva; Irma Herrera-Camacho; Gerardo Santos-López; Thomas Scior
Journal:  Molecules       Date:  2020-09-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.